Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)

NCT07318597 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

99

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Arterial Hypertension (PAH)

Interventions

DRUG: REGN13335
DRUG: Placebo

Sponsor

Regeneron Pharmaceuticals